We are the expertise that we enjoy passing on
4 companies, 1 common vision to better protect, anticipate and personalize.
Contacts us
4 companies, 1 common vision to better protect, anticipate and personalize.
Patient and occupational safety, personalized medicine and predictive imaging
X-ray imaging, nuclear medicine and MRI: managing your facilities (quality assurance), managing your high-risk patients (e.g. patients with implanted devices in MRI and pregnant women/children in X-ray imaging), training your staff, developing new management protocols, optimizing acquisition parameters and sequences have been our expertise for over 15 years at ALARA Expertise and Spin Up
Dosimetry: having a true sentinel that measures the doses actually received by each of your patients allows you to avoid incidents with IVIscan, the world's first detector for scanning developed by Fibermetrix
all about IVIscan
Improving the safety and protection of your staff from radiation is essential !
Analyzing the risks associated with occupational exposure, implementing appropriate protection and prevention measures, drafting information notices and work procedures, taking into account your workers at particular risk (e.g. pregnant women) are necessary steps in risk management
The future lies in personalized medicine, through the adaptation of treatment for each patient.
More information about our tests
Read more about our services
Assessing the reliability of medical data is crucial, mastering it and knowing how to make the most of this information is strategic!
Spin Up is the only company in the world that can calibrate 4D flow MRI sequences and assess geometric distortions in your images.
Thanks to our innovative MRI imaging solutions, control your 4D flow cardiovascular images and access a much higher level of patient-specific biomechanical information than MRI alone. Our long-term objective: to better predict the evolution of aneurysm-like pathologies, in order to adapt patient care.
En tant qu’experts du rayonnement, il nous semble primordial de travailler sur le développement de méthodes prédictives de la toxicité des traitements pour tous les patients.
En 2021, Neolys Diagnostics présente deux premières mondiales :
- RadioDetect©, test de dépistage, permet l’identification des patients à risque afin de découvrir s'ils sont normalement sensibles aux rayonnements ou non
- RadioProfile©, test complet de caractérisation, permet de définir le niveau de radiosensibilité d'un patient
Grâce à ces 2 innovations, le thérapeute aura tous les éléments à sa disposition pour savoir s’il doit adapter le traitement, voire changer de stratégie de prise en charge.
